Authors
Loading...
NIP-142's tertiapin-mimicking atrial effects remain in vitro; leaves open development of IK,ACh-targeted antiarrhythmics.
Key points are not available for this paper at this time.
Matsuda et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: